Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$72.75BHealthcare Market cap, Sector
QuidelOrtho
QDEL$813.86MHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 QDEL
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsQDEL
84B
F21
87A
F19
92A
F34
66C
F36
75B
F0
91A
F26
95A
F19
Side-by-side metrics
| Metric | JSLL.NS | QDEL |
|---|---|---|
| Market cap | Winner: $72.75B | $813.86M |
| P/E (TTM) | 33.3x | - Winner |
| EV/EBIT | 24.1x | - Winner |
| ROIC (TTM) | Winner: 39.15% | -19.88% |
| Gross margin | Winner: 88.58% | 44.96% |
| Net margin | Winner: 27.68% | -45.57% |
| Revenue CAGR 5y | Winner: 57.81% | 12.6% |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | Winner: 0.3x | 1.6x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Net margin27.68%vs -45.57%+161%
- ROIC (TTM)39.15%vs -19.88%+151%
- Market cap$72.75Bvs $813.86M+99%
- Debt / Equity0.3xvs 1.6x+82%
QDEL leads on
- EV/EBIT-vs 24.1x+115%
- P/E (TTM)-vs 33.3x+102%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.